Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2E1 | P05181 | 1/20 | 0.34 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | NR2E1 | Q9Y466 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27916753 | 0.69 | CYP2E1 (0.38) | CYP2E1CYP2A6GAACYP1A2CYP3A4 | |
| SCHEMBL3681890 | 0.67 | — | — | |
| SCHEMBL12610 | 0.67 | — | — | |
| SCHEMBL10070244 | 0.65 | — | — | |
| Hydrochloric Acid SCHEMBL22027392 | 0.65 | — | — | |
| SCHEMBL18520369 | 0.65 | — | — | |
| SCHEMBL27453763 | 0.65 | — | — | |
| SCHEMBL26792795 | 0.65 | — | — | |
| SCHEMBL22068261 | 0.62 | — | — | |
| SCHEMBL23571443 | 0.60 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025227071-A1 | METHODS AND COMPOSITIONS FOR TREATING HEART FAILURE AND LIVER DISEASE | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2025-10-30 | — | — | WO | disclosed |
| US-20240203727-A1 | METHOD OF DEPOSITING SILICON-BASED MATERIAL AND PRECURSORS FOR THE SAME | ASM IP HOLDING B.V. (NL) | 2024-06-20 | — | — | US | disclosed |
| CN-118207515-A | Method for depositing silicon-based materials and precursors thereof | ASM IP私人控股有限公司 | 2024-06-18 | — | — | CN | disclosed |
| US-9899665-B2 | Sodium secondary battery comprising carbonaceous material | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2018-02-20 | — | — | US | disclosed |
| CN-102113153-B | Sodium rechargeable battery | SUMITOMO CHEMICAL CO | 2013-11-20 | — | — | CN | disclosed |
| CN-102113153-A | Sodium rechargeable battery | SUMITOMO CHEMICAL CO | 2011-06-29 | — | — | CN | disclosed |
| US-20110135990-A1 | SODIUM SECONDARY BATTERY | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-06-09 | — | — | US | disclosed |
| US-20100321863-A1 | ACTIVATED CARBON AND PROCESS FOR PRODUCING THE SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-12-23 | — | — | US | disclosed |
| CN-101911349-A | Nonaqueous electrolyte secondary battery, electrode and carbon material | SUMITOMO CHEMICAL CO | 2010-12-08 | — | — | CN | disclosed |
| US-20100248041-A1 | NONAQUEOUS ELECTROLYTE SECONDARY BATTERY, ELECTRODE AND CARBONACEOUS MATERIAL | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-09-30 | — | — | US | disclosed |
| US-6380378-B1 | BIOSYNTHESIS | TOAGOSEI COMPANY, LTD. (JP) | 2002-04-30 | — | — | US | disclosed |
| EP-1195785-A1 | NONAQUEOUS ELECTROLYTIC SOLUTION, ELECTRODE, AND CAPACITOR CONTAINING THE SAME | Mitsui Chemicals, Inc. (JP) | 2002-04-10 | — | — | EP | disclosed |
| US-6335456-B1 | REACTING AN AMIDE WITH SILYLATION AGENT; DISTILLATION | ATOFINA (FR) | 2002-01-01 | — | — | US | disclosed |
| US-20010056200-A1 | Semi-continuous process for preparing bis-silyl carboxamides | ATOFINA (FR) | 2001-12-27 | — | — | US | disclosed |
| US-5939546-A | USEFUL DEOXOFLUORINATION REAGENTS | AIR PRODUCTS AND CHEMICALS, INC. (US) | 1999-08-17 | — | — | US | disclosed |
| EP-0933364-A1 | Imidazolate sulfur difluorides | AIR PRODUCTS AND CHEMICALS, INC. (US) | 1999-08-04 | — | — | EP | disclosed |
| EP-0291212-B1 | POLYMERIZATION OF ACRYLIC ESTERS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1992-06-24 | — | — | EP | disclosed |
| EP-0291212-A1 | Polymerization of acrylic esters | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1988-11-17 | — | — | EP | disclosed |
| US-4771117-A | COCATALYST SYSTEM WITH A TETRACOORDIATE SILICONE ORGANIC COMPOUND | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1988-09-13 | — | — | US | disclosed |
| US-4467063-A | N-SILYL-SUBSTITUTED IMIDAZOLE | GENERAL ELECTRIC COMPANY (US) | 1984-08-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010056200-A1 | Semi-continuous process for preparing bis-silyl carboxamides | ACMSD, BRD4, BICRA | CYP2E1 332/4885CYP2A6 1458/4885GAA 3061/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.